ANPRESSIN
Otsuka Pharmaceutical Co., Ltd.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 74548504 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Domestic Representative | STANLEY W. SOKOLOFF |
| Attorney Name | Stanley W. Sokoloff |
| Attorney Docket Number | 67060.T001 |
| Law Office Assigned | L50 |
| Employee Name | MANDIR, FREDERICK M |
Timeline
| 1994-07-12 | Application Filed |
| 1997-08-12 | Published for Opposition |
| 1999-11-05 | Abandon |
| 1999-11-05 | Status: Dead/Abandoned |
| 2000-02-29 | Location: FILE REPOSITORY (FRANCONIA) |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  OTSUKA PHARMACEUTICAL CO., LTD. |
| Address | 2-9, Kanda Tsukasa-cho Chiyoda-ky, Tokyo JP |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 018 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations for treatment of hypertension, chronic heart failure, glomeruonephritis, diabetic nephropathy and Meniere disease |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1994-12-14 | 1 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 1994-12-16 | 2 DOCK D:Assigned to Examiner |
| LETTER OF SUSPENSION MAILED | 1995-01-03 | 3 CNSL F:First Action |
| INQUIRY AS TO SUSPENSION MAILED | 1995-09-14 | 4 CNSI O:Outgoing Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 1996-03-15 | 5 CRFA I:Incoming Correspondence |
| LETTER OF SUSPENSION MAILED | 1996-05-06 | 6 CNSL F:First Action |
| INQUIRY AS TO SUSPENSION MAILED | 1996-11-27 | 7 CNSI O:Outgoing Correspondence |
| LETTER OF SUSPENSION MAILED | 1997-04-03 | 8 CNSL F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 1997-05-12 | 9 CRFA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1997-05-29 | 10 CNSA P: |
| NOTICE OF PUBLICATION | 1997-07-11 | 11 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1997-08-12 | 12 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 1997-11-04 | 13 NOAM O:Outgoing Correspondence |
| EXTENSION 1 FILED | 1998-04-29 | 14 EXT1 S: |
| EXTENSION 1 GRANTED | 1998-05-19 | 15 EX1G S: |
| EXTENSION 2 FILED | 1998-11-04 | 16 EXT2 S: |
| EXTENSION 2 GRANTED | 1998-12-14 | 17 EX2G S: |
| EXTENSION 3 FILED | 1999-04-21 | 18 EXT3 S: |
| EXTENSION 3 GRANTED | 1999-04-21 | 19 EX3G S: |
| ABANDONMENT - NO USE STATEMENT FILED | 2000-02-27 | 20 ABN6 S: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ANPRESSIN 76182646 not registered Dead/Abandoned |
OTSUKA PHARMACREUTICAL CO., LTD. 2000-12-18 |
 ANPRESSIN 74548504 not registered Dead/Abandoned |
OTSUKA PHARMACEUTICAL CO., LTD. 1994-07-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 